HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Allergy & Immunology
Sys. Review
Systematic review examines immune checkpoint inhibitors, innate immunity, and immune-related adverse events in cancer patients
A review suggests innate immunity plays a key role in cancer drug side effects
This systematic review evaluated immune checkpoint inhibitors (ICIs) in patients with cancer, focusing on immune-related adverse events (irA…
Cancer drugs that help fight tumors can also cause serious inflammation, and new research shows the body's first line of defense plays a key…
Frontiers
Apr 16, 2026
Oncology
Meta-analysis
Meta-analysis links elevated DLEU1 expression to shorter survival in cancer patients
High DLEU1 levels in cancer tissue are linked to shorter life and worse tumor spread
This systematic review and meta-analysis of 938 cancer patients found that elevated DLEU1 expression was associated with shortened overall s…
High levels of a protein called DLEU1 in cancer tissue are linked to shorter life and worse tumor spread across 938 patients.
Frontiers
Apr 16, 2026
Urology
Sys. Review
STING activation targets renal, prostatic, and cancer inflammation in mini-review
The Immune Alarm System in Your Kidneys and Prostate Has a Dark Side
This mini-review discusses STING activation as a potential intervention for renal inflammation, prostatic inflammation, and cancer.
A molecular alarm in kidneys and prostate that fights infection can get stuck on, driving chronic inflammation, scarring, and cancer risk.
Frontiers
Apr 16, 2026
Oncology
Case-Control
Multi-cancer early detection blood test shows variable sensitivity across cancer stages in case-control study
Blood Test Finds Half of Cancers Before Symptoms Start
This case-control study evaluated a multi-target blood test for early cancer detection across 21 tumor types in 6,352 samples.
A new blood test detects half of all cancers before symptoms appear, catching aggressive types often missed by current screening tools.
medRxiv
Apr 16, 2026
Oncology
Sys. Review
Narrative review discusses dual role of senescent cells in cancer immunity and emerging therapeutic strategies
Old Cells Can Fight Cancer
This narrative review examines the complex role of cellular senescence in cancer, specifically focusing on inducing senescence in tumor cell…
Old cells in your body can either kill tumors or help them grow, so new drugs aim to turn these zombie cells into powerful cancer fighters s…
Frontiers
Apr 15, 2026
Oncology
Meta-analysis
Physical activity improves fatigue and muscle strength in pediatric cancer patients based on a meta-analysis of 24 studies
Does moving more help young cancer patients feel better and fight fatigue?
This systematic review and meta-analysis evaluated physical activity (PA) in children and adolescents with cancer across 24 studies.
Getting moving helps young cancer patients feel less fatigued, build stronger muscles, and improve their ability to think clearly and connec…
Frontiers
Apr 14, 2026
Allergy & Immunology
Sys. Review
Systematic review assesses liquid biopsy technologies for early detection of drug resistance and therapeutic response monitoring in people
A Simple Blood Test May Catch When Your Cancer Treatment Stops Working
This systematic review evaluated liquid biopsy technologies, including ctDNA, CTCs, and EVs, for monitoring tumor genomics and customizing t…
A simple blood test can detect when cancer evolves to resist treatment weeks before standard scans show any change.
Frontiers
Apr 14, 2026
Palliative Care
Cohort
Disability benefit take-up varied by cause of death and geography in England and Wales
Millions Miss Out on Money Before Death
This retrospective cohort study examined 1,049,493 decedents aged 16 or older in England and Wales with chronic illnesses.
In England and Wales, one out of three people dying from expected causes like cancer or heart disease never receive the financial benefits t…
medRxiv
Apr 14, 2026
Oncology
RCT
In UK primary care, the NAT-C tool guided consultations resulted in clinical action for 72% of cancer consultations
Why a Simple Cancer-Care Tool Works in Theory but Stalls in Real GP Offices
This mixed-methods process evaluation examined the implementation of the Needs Assessment Tool-Cancer (NAT-C) in 21 UK general practices ser…
A simple cancer needs-assessment tool triggers action in 7 out of 10 doctor visits, but long-term success depends on local support and resou…
Apr 13, 2026
Pediatrics
RCT
Study protocol assesses multimodal activity intervention versus hospital-only activity on gross motor function in preschool children with cancer
A Simple Play Program Could Protect Young Brains During Cancer Treatment
This study protocol outlines a randomized controlled trial involving 82 preschool children (aged 1–5 years) newly diagnosed with cancer.
A simple play program could protect young brains during cancer treatment by helping preschoolers aged 1 to 5 keep growing and learning while…
Frontiers
Apr 13, 2026
Oncology
RCT
Electronic antiemetic device plus ondansetron improved delayed CINV response in 126 cancer patients
A Wearable Buzz on Your Wrist May Ease Chemo Nausea
This single-centre randomized controlled trial enrolled 126 cancer patients receiving moderately or highly emetogenic chemotherapy.
A small device targeting an old acupressure point may give real relief from the days-long nausea that chemo drugs leave behind.
Apr 13, 2026
Oncology
Meta-analysis
mHealth interventions improve medication adherence and self-efficacy in cancer patients, meta-analysis finds
Mobile apps and texts help cancer patients stick to their medication better
A systematic review and meta-analysis of 17 RCTs involving 1309 cancer patients found mobile health interventions significantly improved med…
Phone apps and text reminders make cancer patients about three and a half times more likely to take their medicine on time.
Apr 9, 2026